Difficulty: Medium
Average Score: 91%
Practice
The treatment of choice for childhood onset of major depression is
Correct answer
C
Rationale
The correct answer is C) serotonin reuptake inhibitors for the treatment of childhood onset major depression. Serotonin reuptake inhibitors, such as SSRIs, are considered the first-line pharmacological treatment for pediatric depression due to their safety profile and efficacy in managing symptoms. SSRIs have been shown to be more effective and have fewer side effects compared to other antidepressants in children and adolescents.
Option A) monoamine oxidase inhibitors (MAOIs) are not typically recommended for pediatric patients due to their potential for serious side effects and dietary restrictions. MAOIs are considered second or third-line treatments for depression in adults.
Option B) tricyclic antidepressants (TCAs) are also not usually recommended for children due to their side effect profile, including cardiac toxicity and overdose risk. SSRIs are preferred over TCAs in pediatric patients.
Option D) benzodiazepines are not indicated for the treatment of depression in children. They are commonly used for anxiety disorders or insomnia but are not considered a first-line treatment for depression due to limited efficacy and risk of dependence.
In an educational context, it is crucial for healthcare providers working with pediatric patients to be aware of the most appropriate and evidence-based treatments for childhood depression. Understanding the differences between various classes of antidepressants and their suitability for different age groups is essential for safe and effective management of pediatric mental health conditions.
Option A) monoamine oxidase inhibitors (MAOIs) are not typically recommended for pediatric patients due to their potential for serious side effects and dietary restrictions. MAOIs are considered second or third-line treatments for depression in adults.
Option B) tricyclic antidepressants (TCAs) are also not usually recommended for children due to their side effect profile, including cardiac toxicity and overdose risk. SSRIs are preferred over TCAs in pediatric patients.
Option D) benzodiazepines are not indicated for the treatment of depression in children. They are commonly used for anxiety disorders or insomnia but are not considered a first-line treatment for depression due to limited efficacy and risk of dependence.
In an educational context, it is crucial for healthcare providers working with pediatric patients to be aware of the most appropriate and evidence-based treatments for childhood depression. Understanding the differences between various classes of antidepressants and their suitability for different age groups is essential for safe and effective management of pediatric mental health conditions.